Gyomor- és nyelőcsőrák: vizsgálatok itt: Kanada

In Kanada 36 Also abroad 1280

36 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

1. fázisTaking people
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Where
Montreal, Toronto
Életkor
18 év and over
People
540 worldwide
Run by
Pfizer
See details and how to joinNCT07090499 · EU 2025-521729-33-00
2/3. fázisTaking people
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Where
Calgary, Halifax, Sherbrooke, Toronto
Életkor
18 év and over
People
690 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07221149 · EU 2025-523263-37-00
2. fázisTaking people
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Halifax, Montreal, Toronto
Életkor
18 év and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00
1. fázisTaking people
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Where
Hamilton, Montreal, Toronto
Életkor
18 év and over
People
421 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07114601 · EU 2025-522367-15-00
2. fázisTaking people
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
Where
Montreal, Toronto
Életkor
18 év and over
People
100 worldwide
Run by
AstraZeneca
See details and how to joinNCT07069712 · EU 2024-516909-23-00
1/2. fázisTaking people
BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
Where
Edmonton, Hamilton, Montreal, Ottawa, Toronto
Életkor
18 év and over
People
220 worldwide
Run by
Bold Therapeutics, Inc.
See details and how to joinNCT04421820 · EU 2024-517500-11-00
No phaseNot yet taking people in Kanada
Zolbetuximab and Other Cancer Treatments in People With Advanced Gastric or GEJ Cancer in Clinical Practice (RADIANCE)
Where
Alberta
Életkor
18 év and over
People
1000
Run by
Astellas Pharma Europe Ltd.
See details and how to joinNCT07858500
2. fázisTaking people
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Where
Edmonton, Toronto, Vancouver
Életkor
18 év and over
People
740 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00
1. fázisTaking people
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Where
Toronto, Vancouver
Életkor
18 év and over
People
138 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07360314 · EU 2025-523232-39-00
3. fázisTaking people
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Where
Barrie, Brampton, Calgary, Chicoutimi, Edmonton, Hamilton, Lévis, Montreal, Toronto, Winnipeg
Életkor
18 év and over
People
840 worldwide
Run by
AstraZeneca
See details and how to joinNCT06764875 · EU 2024-512583-57-00
3. fázisTaking people
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Where
Abbotsford British Columbia, Barrie, Brampton, Edmonton, Moncton, Montreal, Ottawa, Québec, Sault Ste. Marie, Toronto, Vancouver, Winnipeg
Életkor
18 év and over
People
2130 worldwide
Run by
AstraZeneca
See details and how to joinNCT07431281 · EU 2024-519787-40-00
2/3. fázisTaking people
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Where
London
Életkor
18 év and over
People
840 worldwide
Run by
Pfizer
See details and how to joinNCT07392892 · EU 2025-524717-86-00
No phaseTaking people
CfDNA in Hereditary And High-risk Malignancies 2
Where
Halifax, Montreal, St. John's, Toronto, Vancouver
Életkor
Up to 90 év
People
1000
Run by
University Health Network, Toronto
See details and how to joinNCT06726642
2. fázisTaking people
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Where
Kingston, Montreal, Sherbrooke, Toronto
Életkor
18 év and over
People
226 worldwide
Run by
AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00
2. fázisTaking people
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Where
Montreal, Québec, Toronto
Életkor
18 év to 130 év
People
454 worldwide
Run by
AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00
2. fázisTaking people
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Where
Edmonton, Montreal
Életkor
18 év to 64 év
People
257 worldwide
Run by
AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00
1/2. fázisTaking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Edmonton, Hamilton, Montreal, Ottawa, Toronto, Vancouver
Életkor
18 év and over
People
1109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
1/2. fázisTaking people
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Where
Toronto
Életkor
18 év and over
People
366 worldwide
Run by
Marengo Therapeutics, Inc.
See details and how to joinNCT05592626 · EU 2023-505334-10-01
3. fázisTaking people
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Where
Laval, Mississauga, Montreal, Sherbrooke, Toronto
Életkor
18 év and over
People
726 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06731478
1. fázisTaking people
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Where
Montreal, Toronto
Életkor
18 év and over
People
714 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00
1. fázisTaking people
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Where
Montreal, Ottawa, Toronto
Életkor
18 év and over
People
914 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00
2. fázisNot yet taking people in Kanada
RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) Trial
Where
Montreal
Életkor
18 év and over
People
184
Run by
McGill University Health Centre/Research Institute of the McGill University Health Centre
See details and how to joinNCT07625930
1. fázisTaking people
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Where
Calgary, Montreal, Toronto
Életkor
18 év and over
People
694 worldwide
Run by
AbbVie
See details and how to joinNCT05005403
No phaseTaking people
FAZA PETMRI Gastro-Oesophageal Study
Where
Toronto
Életkor
18 év and over
People
40
Run by
University Health Network, Toronto
See details and how to joinNCT04560036
1. fázisNot yet taking people in Kanada
Outside the Cage (OTC) Robotic Esophagectomy
Where
Montreal
Életkor
18 év and over
People
31
Run by
Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT06735638